# Mechanism of Action Trial of ColoAd1

> **NCT02053220** · PHASE1 · COMPLETED · sponsor: **Akamis Bio** · enrollment: 17 (actual)

## Conditions studied

- Resectable Colon Cancer
- Resectable Non-small Cell Lung Cancer
- Resectable Bladder Cancer
- Resectable Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** Colo-Ad1

## Key facts

- **NCT ID:** NCT02053220
- **Lead sponsor:** Akamis Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053220, "Mechanism of Action Trial of ColoAd1". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02053220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*